$0.15
0.0007[0.47%]
At close: May 13
$0.15
0[0.00%]
PreMarket: 9:04AM EDT
Kintara Therapeutics
(NASDAQ:KTRA)Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 104.755K / 14.295M |
| Day Range | - - - |
| 52 Wk Range | 0.081 - 5.600 |
| Market Cap | $5.856M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 56 |
| Short Interest | 1.79% |
| Days to Cover | 1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Virios Therapeutics (NASDAQ:VIRI), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), NexImmune (NASDAQ:NEXI) and Genprex (NASDAQ:GNPX).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Friday, July 14, 2023. The analyst firm set a price target for 14.00 expecting KTRA to rise to within 12 months (a possible 9233.33% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $0.15 last updated Today at May 13, 2024 at 9:04 AM EDT.
Does Kintara Therapeutics (KTRA) pay a dividend?
There are no upcoming dividends for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q3 earnings are confirmed for Friday, May 24, 2024.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.